Dingdang Health: Cumulative Share Buybacks Reach 68.14 Million Shares, 5.16% of Prior Share Capital

Bulletin Express05-21

Dingdang Health Technology Group reported a Next Day Disclosure Return dated 21 May 2026.

The company’s issued share capital remained unchanged at 1,319,472,897 ordinary shares as of 21 May 2026.

Latest repurchase • Date: 21 May 2026 • Volume: 899,500 shares • Price range: HKD 0.88–0.93 • Consideration: HKD 0.81 million • All shares will be cancelled.

Progress of the 28 May 2025 buy-back mandate • Total mandate: 131.95 million shares • Cumulative repurchases to date (25 Nov 2025–21 May 2026): 68.14 million shares • Proportion of share capital at mandate date: 5.16% • Remaining mandate balance: approximately 63.81 million shares.

All repurchases were executed on the Hong Kong Stock Exchange and complied with the Main Board Listing Rules. A 30-day moratorium on new share issues or treasury-share sales is in effect until 20 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161815070?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 18:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161815070","market":"hk","top_or_hot":-1,"title":"Dingdang Health: Cumulative Share Buybacks Reach 68.14 Million Shares, 5.16% of Prior Share Capital","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group reported a Next Day Disclosure Return dated 21 May 2026.</p>\n<p>The company’s issued share capital remained unchanged at 1,319,472,897 ordinary shares as of 21 May 2026.</p>\n<p>Latest repurchase  \n• Date: 21 May 2026  \n• Volume: 899,500 shares  \n• Price range: HKD 0.88–0.93  \n• Consideration: HKD 0.81 million  \n• All shares will be cancelled.</p>\n<p>Progress of the 28 May 2025 buy-back mandate  \n• Total mandate: 131.95 million shares  \n• Cumulative repurchases to date (25 Nov 2025–21 May 2026): 68.14 million shares  \n• Proportion of share capital at mandate date: 5.16%  \n• Remaining mandate balance: approximately 63.81 million shares.</p>\n<p>All repurchases were executed on the Hong Kong Stock Exchange and complied with the Main Board Listing Rules. A 30-day moratorium on new share issues or treasury-share sales is in effect until 20 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health: Cumulative Share Buybacks Reach 68.14 Million Shares, 5.16% of Prior Share Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health: Cumulative Share Buybacks Reach 68.14 Million Shares, 5.16% of Prior Share Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-21 18:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group reported a Next Day Disclosure Return dated 21 May 2026.</p>\n<p>The company’s issued share capital remained unchanged at 1,319,472,897 ordinary shares as of 21 May 2026.</p>\n<p>Latest repurchase  \n• Date: 21 May 2026  \n• Volume: 899,500 shares  \n• Price range: HKD 0.88–0.93  \n• Consideration: HKD 0.81 million  \n• All shares will be cancelled.</p>\n<p>Progress of the 28 May 2025 buy-back mandate  \n• Total mandate: 131.95 million shares  \n• Cumulative repurchases to date (25 Nov 2025–21 May 2026): 68.14 million shares  \n• Proportion of share capital at mandate date: 5.16%  \n• Remaining mandate balance: approximately 63.81 million shares.</p>\n<p>All repurchases were executed on the Hong Kong Stock Exchange and complied with the Main Board Listing Rules. A 30-day moratorium on new share issues or treasury-share sales is in effect until 20 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1161815070","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161815070","pubTimestamp":1779359131,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group reported a Next Day Disclosure Return dated 21 May 2026. The company’s issued share capital remained unchanged at 1,319,472,897 ordinary shares as of 21 May 2026....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康：累计回购股份达6814万股占事前股本5.16%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group reported a Next Day Disclosure Return dated 21 May 2026.\nThe company’s issued share capital remained unchanged at 1,319,472,897 ordinary shares as of 21 May 2026.\nLatest repurchase  \n• Date: 21 May 2026  \n• Volume: 899,500 shares  \n• Price range: HKD 0.88–0.93  \n• Consideration: HKD 0.81 million  \n• All shares will be cancelled.\nProgress of the 28 May 2025 buy-back mandate  \n• Total mandate: 131.95 million shares  \n• Cumulative repurchases to date (25 Nov 2025–21 May 2026): 68.14 million shares  \n• Proportion of share capital at mandate date: 5.16%  \n• Remaining mandate balance: approximately 63.81 million shares.\nAll repurchases were executed on the Hong Kong Stock Exchange and complied with the Main Board Listing Rules. A 30-day moratorium on new share issues or treasury-share sales is in effect until 20 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161815070","isCrawlerRequest":true}